An open-label randomized active-controlled phase II clinical study to assess the efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer (PROFECTA-II/GOG-3044)
- DOI
- 10.1016/j.ygyno.2025.03.001
- Published
- 2025-03
- Container
- Gynecologic Oncology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ygyno.2025.03.001,
title = {An open-label randomized active-controlled phase II clinical study to assess the efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer (PROFECTA-II/GOG-3044)},
author = {Thomas J. Herzog and John B. Liao and Karen Finkelstein and Lyndsay Willmott and Wei Duan and John W. Moroney and Joseph Buscema and Katie Campbell-Simms and Yong Yue and Susan Zweizig and Juan Liu and Xiaoyu Wang and Rong-Yu Zang and Rutie Yin and David M. O'Malley and Lingying Wu},
year = {2025},
journal = {Gynecologic Oncology},
doi = {10.1016/j.ygyno.2025.03.001},
url = {https://doi.org/10.1016/j.ygyno.2025.03.001}
}RIS
TY - JOUR TI - An open-label randomized active-controlled phase II clinical study to assess the efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer (PROFECTA-II/GOG-3044) AU - Thomas J. Herzog AU - John B. Liao AU - Karen Finkelstein AU - Lyndsay Willmott AU - Wei Duan AU - John W. Moroney AU - Joseph Buscema AU - Katie Campbell-Simms AU - Yong Yue AU - Susan Zweizig AU - Juan Liu AU - Xiaoyu Wang AU - Rong-Yu Zang AU - Rutie Yin AU - David M. O'Malley AU - Lingying Wu PY - 2025 JO - Gynecologic Oncology DO - 10.1016/j.ygyno.2025.03.001 UR - https://doi.org/10.1016/j.ygyno.2025.03.001 ER -
APA
Herzog, T. J., Liao, J. B., Finkelstein, K., Willmott, L., Duan, W., Moroney, J. W., Buscema, J., Campbell-Simms, K., Yue, Y., Zweizig, S., Liu, J., Wang, X., Zang, R., Yin, R., O'Malley, D. M., & Wu, L. (2025). An open-label randomized active-controlled phase II clinical study to assess the efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer (PROFECTA-II/GOG-3044). Gynecologic Oncology. https://doi.org/10.1016/j.ygyno.2025.03.001
Source records
- crossref · retrieved 2026-09-27T14:18:16.243Z